What Does the Liver Do, and What Do Liver Tests Measure? — The Factory at the Gate, and the Signal That Leaks Through the Wall

"My Liver Numbers Are a Bit High"

When someone receives their health checkup results, they hear that their "liver numbers are a bit high." They wonder why, since they do not drink much alcohol, and whether those numbers mean the liver cannot do its job. If the phrase "the silent organ," which rarely shows when it is hurting, comes to mind, the worry grows even larger.

The liver is the largest organ in the body, located in the upper right side of the abdomen, and it receives blood coming from the intestines first to store, transform, and send out nutrients. Liver numbers are a term that groups together the values measured by drawing a little blood to check the amounts of various substances related to the liver. On the test report, the name "liver function test" is commonly attached.

This article first follows what the liver does, and then looks at what each line of the liver numbers measures. Among those lines, the ones that measure enzymes reflect the traces of liver injury rather than the amount of work the liver has accomplished (PMID 26842972).

The Place That Receives Blood from the Gut First

The liver receives blood through two main routes. Of the blood the heart pumps out at once, 25% enters the liver through two paths: the hepatic artery and the hepatic portal vein (PMID 35545561). The fine blood vessels inside the liver are of two types: branches coming from the artery and branches coming from the portal vein (PMID 1289084). The artery brings oxygen-rich blood like other organs do, while the portal vein brings blood that has passed through the gut.

The hepatic portal vein is a blood vessel that sends blood carrying what the stomach and gut absorbed to the liver before sending it to the heart. The liver is the first large organ positioned right after the gut, and blood coming out of the gut enters the liver along the hepatic portal vein. Thanks to this layout, the liver directly receives and processes blood loaded with nutrients just absorbed from the gut (PMID 40461700). Sugar from a meal also reaches the liver straight from the gut through this path (PMID 27707936).

Therefore, whatever is absorbed in the gut and loaded into the blood passes through the liver first before spreading throughout the entire body. It can be compared to a factory standing at the front gate.

Hepatocytes are the main cells that make up the liver and handle most of the work the liver does. Hepatocytes are the workers in the factory called the liver; they process nutrients and substances coming from outside the body, build and recycle proteins, and balance sugar and fat in the blood. Work is divided among different stations inside the liver, handling multi-step tasks in sequence like an assembly line (PMID 36693201).

Every single hepatocyte also works in two directions. It takes things in on the side facing the blood and sends what it has made out to the opposite side (PMID 1289084). Compared to a factory, it has separate doors for coming in and going out.

The liver is a factory at the front gate that receives blood from the gut before the rest of the body does, takes it in, alters it, and sends it out.

What a Factory Does — Storing, Making, and Changing to Send Out

After you eat, the sugar absorbed in the gut rides the hepatic portal vein into the liver. The liver stores sugar after a meal, and while you fast, it makes sugar and sends it out into the blood (PMID 28731034).

Glycogen is a storage form in which multiple glucose molecules are linked together in a chain and stored in the liver and muscles. The liver is the main place inside the body that makes sugar, and a large warehouse that stores sugar as glycogen (PMID 38308003). When a meal has been fully absorbed and you are resting, the path of pulling out stored glycogen and the path of newly making it from non-glucose materials send sugar out of the liver in roughly equal shares (PMID 8379904). How blood sugar is held steady is covered in "How Blood Sugar Stays Steady — A Letter to Store, a Letter to Release".

Factories also make things. The liver is the organ that makes proteins carried in the blood (PMID 34120768). Albumin is a protein made by the liver and sent out into the blood, and is the most abundant protein in the blood of a healthy person. Albumin does the job of carrying various substances inside the blood (PMID 3281888). Since the liver is the only place that makes albumin, if the liver is suddenly or long damaged, albumin in the blood drops (PMID 37540192, PMID 38099350).

Clotting factors are proteins in the blood that help blood clot to block wounds. When the liver's ability to make proteins drops, these proteins that clot blood also decrease (PMID 26080306). Therefore, the time it takes for blood to clot is used as a test reflecting the liver's protein-making ability (PMID 24266911).

Another thing the liver makes is bile. Digestive enzymes are proteins that cut large molecules in food into small pieces that the body can absorb. Bile is a liquid made by the liver and sent out into the intestine, which breaks up fat finely so digestive enzymes can reach it. Bile is made by liver cells and flows into very thin channels between the liver cells, and these channels gather into increasingly thick paths that lead to the pouch that stores bile and the intestine (PMID 23897680). Among the components contained in bile, some are made by the liver breaking down cholesterol, and these components are essential in the intestine for absorbing fat in food and fat-soluble vitamins (PMID 25073467).

Bile is also an exit of the factory. Along with components that help digest fat, bile loads products made by the liver grooming potentially harmful substances and sends them to the intestine to go out of the body in stool (PMID 17602352).

Here comes the actual meaning of the phrase "the liver detoxifies". Detoxification is the work where the liver changes drugs or chemical substances that came in from outside the body into a form that dissolves well in water, making them easy to send out of the body. The liver changes substances that dissolve well in oil into products that dissolve better in water and sends them out efficiently in urine, and the types of enzymes that do this work are diverse, allowing it to handle all sorts of chemicals encountered day by day (PMID 1749210). However, certain substances are actually changed into more harmful forms precisely because of these enzymes (PMID 1749210).

Harmful substances generated inside the body are also handled by the liver. Ammonia is a toxic substance, and if the liver cannot do its job, it builds up in the blood (PMID 39251708). Alcohol is also one of the substances the liver handles. Because the liver is the organ mainly in charge of detoxification in the body, it is especially vulnerable to damage from alcohol and substances entering from outside the body (PMID 40845633).

Talk of products putting forward "detox" or "liver cleansing" is separate from this physiology. The evidence this article relies on does not cover such products.

The liver's detoxification is the work of changing incoming substances and sending them out, and its exits are urine and bile.

A Factory That Regrows Even When Injured

If a part of the liver is cut away, the remaining liver cells divide and multiply again, and the liver fills in as much as it lost (PMID 10728791, PMID 12115866). Liver regeneration is the process by which remaining liver cells multiply to fill in the lost parts of the liver, returning it to the size the body needs.

A review paper notes that the liver is the only solid organ that always recovers 100% of the size suited to body weight. According to the same review, the lungs and kidneys also adapt when they lose tissue, but they do not return to their original 100% (PMID 32764740). Even while regrowing, the liver usually continues to do its job (PMID 12086922).

This power is also used in human surgeries. Because the liver's capacity to regrow is large, surgeries to cut away part of the liver or transplants to move only a part of the liver can be performed safely (PMID 33182515). In both experiments and patients, if up to two-thirds of the liver is removed, the remaining liver regrows quickly and in an organized way, and the remaining liver carries on normal liver work (PMID 32906177).

Conditions that affect regeneration after surgery include older livers, fatty livers, and treatments that suppress immunity (PMID 33182515). However, the detailed processes of how regeneration starts and stops have been revealed primarily through animal experiments where a part of the liver was cut away, and are still being uncovered today (PMID 10728791, PMID 32764740, PMID 32906177). Also, in a normal liver that has never been injured, the rate at which liver cells turnover is very slow (PMID 32764740).

Regeneration does not always go well. There are times when the regenerative response fails to happen at all, goes awry, or stops short, and such misdirected regeneration plays a part in the sudden state where the liver stops working, the disease where the liver hardens with scars, and the development of cancers that start in the liver (PMID 12086922). The same review notes that regrowing after a single acute injury is always beneficial, but when liver cells are lost for a long time due to various causes, it is common for scars to build up, the liver to harden, and bad outcomes like tumors to develop (PMID 32764740). The path where the liver is damaged and hardens over a long time is taken over by another piece in this series, the piece covering the path where the liver hardens.

The liver is also called the "silent organ." Blood tests can find acute and chronic damage to the liver before symptoms appear (PMID 24266911). This means the liver may be getting injured even while the body says nothing at all.

The liver is an organ with a great power to refill lost parts, but that power also has limits, and if damage continues for a long time, regeneration itself can go wrong.

The Trap Named "Liver Function Tests"

In its 2017 guidelines, the American College of Gastroenterology (ACG) noted that these tests should be called "liver chemistry tests" or simply "liver tests" (PMID 27995906). Among these tests, several enzyme measurements do not gauge the liver's function; instead, they serve as markers signaling damage to the liver (PMID 26842972).

AST and ALT are enzymes abundant inside liver cells, and when liver cells are injured, these enzymes leak out into the blood, raising test values. Enzymes are proteins that help chemical reactions inside the body. Rising ALT and AST levels are a sign that liver cells have been injured (PMID 41831501). Compared to a factory, this is like measuring what leaked out to the outside when cracks formed in the factory walls.

Alkaline phosphatase is an enzyme listed as ALP on lab sheets, and its blood level rises when the pathways flowing with bile become blocked. A rise in ALP is a sign that bile flow has been blocked or reduced (PMID 41831501). Guidelines state that for an elevation of ALP confirmed to originate from the liver, one should run tests to look for diseases of the bile ducts (PMID 27995906), which carries the implication that ALP could also come from outside the liver. Even in the absence of any disease, some enzyme levels can appear higher during pregnancy or adolescence (PMID 27824421). Guidelines define a pattern where AST and ALT are prominently elevated compared to ALP as hepatocellular injury, and a pattern where ALP is prominently elevated compared to AST and ALT as injury on the side of blocked bile flow (PMID 27995906).

Gamma-glutamyl transferase is an enzyme listed as GGT or γ-GT on lab sheets. It is found on the surface of most cells in the body and is particularly common on liver cells (PMID 27512925). Gamma-glutamyl transferase goes up in diseases where bile ducts are blocked, heavy drinking, and certain medications (PMID 11563810). One review notes that enzyme elevation patterns are divided into three branches, and these patterns are used to choose the next tests. In that review, a pattern where both ALP and gamma-glutamyl transferase are high points to disease on the side of bile flow, while a pattern where gamma-glutamyl transferase is prominently elevated is seen in alcohol-related or non-alcohol-related fatty liver disease, as well as diseases where other tissues infiltrate the liver (PMID 27824421). Fatty liver is a condition where fat accumulates excessively in liver cells.

Gamma-glutamyl transferase is also used as a marker for excessive alcohol consumption, but because no single blood test can reliably single out excessive drinking on its own, multiple markers are bundled together alongside medical history and questionnaires (PMID 40711388). People with high gamma-glutamyl transferase also had higher mortality rates. It is thought that part of this is because gamma-glutamyl transferase moves alongside other risk factors, and part is because gamma-glutamyl transferase independently predicts risk (PMID 11563810). This, too, is an association derived from observation.

There are separate lines that reflect whether the liver is actually carrying out its work. Albumin, clotting time, and bilirubin are the tests that look at the liver's function (PMID 41831501). Albumin and clotting time look at the liver's capacity to make proteins, while bilirubin looks at the liver's job of processing substances (PMID 24266911). Compared to a factory, this is the ledger recording the goods the factory actually produced and shipped out, alongside the freight it processed and cleared away.

Bilirubin is a yellow pigment produced when red blood cells reaching the end of their lifespan break down, which the liver takes up and sends out into bile. Bilirubin is the final product of the pathway where heme—which makes up hemoglobin inside red blood cells—is broken down in the blood (PMID 40973744). INR is a value adjusted so that blood clotting times measured across different laboratories can be compared, and it grows larger the longer the blood takes to clot. When an increase in damage-signaling enzymes is accompanied by a growing INR and rising bilirubin, a review notes this as a case requiring more prompt evaluation (PMID 41831501).

The function-side lines have their limitations as well. The liver makes less albumin when the body is stressed by the environment, nutrition, toxic substances, or trauma (PMID 3281888). The cause of low albumin is not always in the liver. In people whose livers have been injured and hardened for a long time, proteins that clot blood and proteins that prevent clotting decrease together so that the balance is readjusted to some degree, and thus the old idea of gauging bleeding risk with traditional clotting time tests is collapsing (PMID 26080306). Commonly used liver tests reflect only a portion of the liver's functions, and there is no test that measures all of the liver's functions at once (PMID 35677506).

Enzymes including AST and ALT are not exclusively found in the liver either (PMID 37482588). Moreover, how high any single number is does not directly tell you how severe a disease is. The degree to which ALT and AST are elevated is used to decide what to investigate first (PMID 27995906), and the severity of liver damage is better gauged by a score bundling multiple values together rather than any single value (PMID 26842972).

The lines of liver numbers measure different things. AST and ALT reflect liver cell damage, ALP reflects the bile duct side, gamma-glutamyl transferase reflects the bile ducts along with alcohol and medications, and albumin, INR, and bilirubin reflect the work the liver actually carries out.

Slightly Off Numbers, Numbers Within the Range

Discovering an out-of-range liver test result by chance is common across virtually all medical departments. A significant portion of such individuals do not actually have a disease in the liver itself, because most of the commonly measured markers are not exclusively found in the liver and fluctuate in response to numerous factors unrelated to liver disease (PMID 26842972).

When liver numbers are out of range, the first things a doctor asks about are metabolic risk factors, alcohol, medications, herbal medicines, and dietary supplements (PMID 41831501). Diseases outside the liver can similarly elevate enzyme levels (PMID 27824421). If an explanation does not emerge from inside the liver, the search turns to causes outside of it (PMID 41831501).

One review article recommends watching and retesting mild elevations in asymptomatic individuals. The reason is that more than 30% of elevated AST and ALT levels return to normal on their own while being watched, which conversely means the rest did not return to normal in the meantime (PMID 27824421). The abstract of this review does not specify what kinds of people were observed or for how long.

There is also evidence on the other side. Several studies have linked high ALT to an increased risk of dying from liver-related causes (PMID 27995906). This link comes from observational data, and the same guidelines treat high ALT as something that warrants evaluation.

Where to draw the line is also not universally fixed. The reference range is the span that captures the middle 95% of values gathered from healthy people, after trimming off the top and bottom 2.5% each. With a range drawn this way, about 1 in 20 healthy people will fall outside the range. What should be considered an abnormal liver test is a question that needs to be decided in its own right, to the extent that British Society of Gastroenterology (BSG) guidelines address it separately as their first question (PMID 29122851). The American College of Gastroenterology's 2017 guidelines propose upper limits of normal for ALT separately for men and women based on truly healthy people, and state that values higher than those should be evaluated (PMID 27995906). The range printed on a test report is the line drawn by that laboratory, and where that line is drawn varies by medical society and laboratory.

A number within the range does not mean there is no disease either. A 2000 review estimated that up to about one-fourth of people infected with the chronic hepatitis C virus (ranging from 10% to 40% depending on the study) keep their AST and ALT within the normal range persistently. When liver tissue is sampled from such people, anywhere up to 80% show some degree of chronic liver damage. However, most of that damage appears mild and does not progress to more severe liver disease, with scars accumulating more slowly than in people with high numbers (PMID 11142566). Hepatitis C itself is covered in the piece dealing with the path of a hardening liver.

Slightly off liver numbers are common and have diverse causes, yet they are not signals to simply brush past, nor does a number within the range serve as a guarantee that there is no disease.

When Your Eyes Turn Yellow — Jaundice

Jaundice is when bilirubin builds up in the blood, turning the whites of the eyes and the skin yellow. Bilirubin in the blood generally needs to exceed 2.5 to 3 mg/dL before it visibly shows on the outside (PMID 27904243). Bilirubin that rises less than that is not visible to the eye and is only caught by tests.

There are multiple paths along which bilirubin accumulates. When red blood cells break down heavily and produce a large amount of bilirubin, or when the liver's capacity to process bilirubin is weak, the form of bilirubin before liver processing builds up. When liver cells are damaged by viruses or alcohol, or when the bile duct is blocked by stones or a tumor, the form of bilirubin after liver processing builds up (PMID 28145671). Therefore, guidelines dictate that when bilirubin rises, it should be measured by dividing it into these two forms (PMID 27995906).

Because you cannot tell which path is at fault from the appearance of yellowing eyes and skin alone, the cause is sorted out step-by-step (PMID 27904243). Initial tests include fractionated bilirubin, a blood cell count, AST, ALT, gamma-GT, ALP, albumin, coagulation time, and INR, and depending on the cause, imaging tests like an abdominal ultrasound or CT are performed (PMID 39823630). Reviews treat jaundice as something that can be a signal of a serious disease in the liver or bile duct (PMID 39823630).

Jaundice is a sign that bilirubin has accumulated, and to know why it accumulated, you must figure out which among the red blood cells, liver cells, and bile ducts has gone wrong.

Reading the Liver Function Lines on a Health Checkup Report as a Factory

Let's look at one person's checkup report and write down what we saw earlier. ALT is slightly above the reference range, and the rest of the lines are within the range. What we will do here is only go as far as confirming which part of the factory each line illuminates.

The first group is the lines that measure what leaked out beyond the wall. The rise of ALT and AST reflects liver cell damage (PMID 41831501). However, a significant number of people who receive such incidentally out-of-range test results do not have a disease in the liver itself. This is because most of the markers commonly measured are not found only in the liver, and fluctuate according to many factors unrelated to liver disease (PMID 26842972). A single number also does not tell us the degree of injury (PMID 26842972).

The second group is the lines that illuminate the outgoing pathway side. ALP illuminates the bile duct side (PMID 41831501), and GGT moves in response to alcohol and medications as well as the bile duct (PMID 11563810).

The third group is the organ side lines. Bilirubin, albumin, and INR fall here, but these tests illuminate only part of what the liver does (PMID 35677506).

Reading these lines to fit one person does not end with just three groups. Over 30% of mild elevations return to normal when measured again (PMID 27824421); conversely, studies show that a high ALT is associated with an increase in liver-related deaths, and guidelines view this as a target for evaluation (PMID 27995906). The cutoff lines themselves also vary by laboratory and guideline. As in the case of chronic hepatitis C, there are people who have mild damage to the liver even though their numbers are all within the range (PMID 11142566).

When evaluating liver numbers, we ask about medical history, look at metabolic risk factors, alcohol, medications, and supplements, perform a physical examination, and add an abdominal imaging scan if necessary to sort out the cause, urgency, and complications of the injury (PMID 41831501). What we can do with the factory analogy is only go as far as knowing which part of the factory each line illuminates. What those lines mean for an individual is read by a doctor within this context.

Where to Look Next

There is not yet a single test that measures all the many things the liver does at once, which is why multiple figures and composite scores that combine them are used together (PMID 35677506).

The same structure for reading the numbers on a health checkup sheet can also be found in "What Do Blood Sugar Tests Measure? — Three Numbers, and the Lines Each Organization Drew" and "What Cholesterol Is and Why We Measure It — Four Lines on a Blood Test, and the Packages They Name". Why the same numbers are read differently depending on who they come from is covered by "What a Test Actually Tells You — An Introduction to Sensitivity, Specificity, and Pretest Probability". The signal to take out and use the glycogen stored by the liver is followed by "How Blood Sugar Stays Steady — A Letter to Store, a Letter to Release".

The pathway from the intestine to the liver and the role of bile in digestion can be seen in another installment of this series, "How Does Digestion Work? — A Tube Through the Body, and a Wall Only Small Pieces Can Cross". Fatty liver, hepatitis, the path where damage accumulates over time and the liver hardens, and the stretch where it can be reversed are taken up by "How Do Fatty Liver, Hepatitis and Cirrhosis Connect? — Ground That Hardens as Scars Build Up, and the Stretch Where You Can Still Turn Back".

Source Papers

• "Evaluation of Abnormal Liver Biochemical Test Results." (2026) — PMID 41831501 — Elevated ALT and AST reflect hepatocyte injury; extended INR or elevated bilirubin calls for more prompt evaluation; elevated ALP indicates cholestasis or impaired bile flow; albumin, PT, and bilirubin serve as liver function tests; evaluation sorts out causes, acuteness, and complications using metabolic risk factors, alcohol, drug/herbal supplement history, physical examination, and imaging; investigate extrahepatic causes if no explanation is found.
• "ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries." (2017) — PMID 27995906 — Should be called "liver chemistry tests/liver tests"; hepatocellular injury = AST and IL-T rise disproportionately to ALP; high ALT is linked to increased liver-related mortality; proposes a normal upper limit of ALT based on truly healthy individuals separately for men and women, with values above that requiring evaluation; the degree of elevation guides the direction of evaluation; ALP elevations confirmed to be of hepatic origin warrant testing for biliary tract diseases; total bilirubin is fractionated into direct and indirect.
• "Evaluation of abnormal liver function tests." (2016) — PMID 26842972 — Incidental abnormalities are common; a substantial proportion involve no primary liver disease (markers are not liver-specific and are influenced by factors unrelated to the liver); enzyme levels are markers of injury, not function; the severity of injury is better captured by a composite score like MELD than by a single number.
• "Liver architecture." (1992) — PMID 1289084 — Liver microvessels have two inflow branches, the artery and the portal vein; hepatocytes operate in two directions, taking up from the vascular side and secreting toward the bile side.
• "Liver macrophages: development, dynamics, and functions." (2025) — PMID 40461700 — The liver is the first major organ downstream of the gut, where blood arriving from the intestines enters the portal vein to directly receive and process nutrient-rich blood.
• "Liver glucose metabolism in humans." (2016) — PMID 27707936 — The liver directly receives dietary carbohydrates from the gut via the portal vein, synthesizing glycogen for the most part postprandially.
• "Spatiotemporal Metabolic Liver Zonation and Consequences on Pathophysiology." (2023) — PMID 36693201 — Hepatocytes are the main workers of the "liver factory" (metabolizing nutrients and xenobiotics, producing and recycling proteins, maintaining glucose and lipid homeostasis), with zonal division of labor carrying out multistep processes like an assembly line.
• "Regulation of hepatic glucose metabolism in health and disease." (2017) — PMID 28731034 — The liver makes glucose during fasting and stores it after a meal.
• "Hepatic glucose metabolism in the steatotic liver." (2024) — PMID 38308003 — The liver is the largest contributor to endogenous glucose production and the largest reservoir of glucose in the form of glycogen.
• "Control of glycaemia." (1993) — PMID 8379904 — In the postabsorptive steady state, hepatic glucose output is split equally between glycogenolysis and gluconeogenesis.
• "Autophagy in liver diseases: A review." (2021) — PMID 34120768 — The liver is a metabolic organ responsible for plasma protein synthesis, gluconeogenesis and glycogen storage, cholesterol metabolism and bile salt synthesis, and drug and xenobiotic metabolism and detoxification.
• "Serum albumin." (1988) — PMID 3281888 — The liver produces albumin in large quantities and reduces production during environmental, nutritional, toxic, or traumatic stress; it acts as a transport protein, and acute-phase protein synthesis and albumin synthesis have an inverse relationship.
• "Controversies regarding albumin therapy in cirrhosis." (2025) — PMID 37540192 — Albumin is synthesized exclusively in the liver; serum albumin decreases in acute and chronic liver disease.
• "Albumin, an interesting and functionally diverse protein, varies from 'native' to 'effective' (Review)." (2024) — PMID 38099350 — Albumin is synthesized in the liver and is the most abundant protein in the plasma of healthy individuals.
• "Liver Disease and Hemostatic (Dys)function." (2015) — PMID 26080306 — In cirrhosis, procoagulant factors decrease due to impaired synthetic capacity, while anticoagulant factors decrease in parallel to reset the balance, dismantling the old paradigm of viewing PT and aPTT as predictive indicators of bleeding risk.
• "Bile formation and secretion." (2013) — PMID 23897680 — Bile is an aqueous secretion produced by hepatocytes, traveling from canaliculus between hepatocytes through progressively larger bile ducts into the gallbladder, common bile duct, and gut.
• "Bile acid signaling in metabolic disease and drug therapy." (2014) — PMID 25073467 — Bile acids are the end products of cholesterol breakdown, essential for the absorption, transport, and metabolism of dietary fats and fat-soluble vitamins in the intestine.
• "Biliary lipid secretion." (2007) — PMID 17602352 — The two functions of bile: delivery of bile acids to aid fat digestion and absorption, and excretion of potentially toxic liver-derived metabolic waste products into the intestine for elimination in feces.
• "Detoxification pathways in the liver." (1991) — PMID 1749210 — The liver protects the body by converting lipophilic substances into water-soluble metabolites for urinary excretion; various enzyme systems process chemical structures encountered daily, though some chemicals are converted into even more toxic metabolites.
• "Ammonia-induced stress response in liver disease progression and hepatic encephalopathy." (2024) — PMID 39251708 — Ammonia levels are regulated by pathways centered on the urea cycle, with toxic ammonia accumulating due to impaired liver function.
• "Xenobiotic-induced liver injury: Molecular mechanisms and disease progression." (2025) — PMID 40845633 — Because the liver is the body's primary detoxification organ, it is particularly vulnerable to environmental xenobiotics such as alcohol.
• "Liver regeneration." (2000) — PMID 10728791 — Hepatic resection or hepatocyte loss triggers hepatocyte replication, with mechanism studies relying mainly on partial hepatectomy and chemical injury animal models.
• "Hepatic stem cells." (2002) — PMID 12115866 — Rapid regenerative response following partial resection restores liver mass, primarily through hepatocyte self-duplication.
• "Liver regeneration: biological and pathological mechanisms and implications." (2021) — PMID 32764740 — The liver is the only solid organ that consistently restores its liver-to-body weight ratio to 100% (lungs, kidneys, and pancreas adapt but do not return to 100%); experimental models use partial resection and chemical injury; regeneration after acute injury is always beneficial, whereas chronic hepatocyte loss leads to fibrosis, cirrhosis, and tumors; cell turnover in the normal liver is very slow.
• "Bilirubin: translational perspectives." (2026) — PMID 40973744 — Bilirubin is the end product of intravascular heme degradation pathways.
• "Liver Regeneration after Hepatectomy and Partial Liver Transplantation." (2020) — PMID 33182515 — Thanks to its great regenerative capacity, partial liver resection and partial liver transplantation are performed safely; regeneration after resection and transplantation involves more abrupt changes in portal blood flow, and marginal livers such as those in older adults or with fatty liver, along with immunosuppression, influence regeneration.
• "Hemostasis and Liver Regeneration." (2020) — PMID 32906177 — In both experiments and patients, removal of up to two-thirds of liver mass is followed by rapid, coordinated regeneration by the remnant liver to maintain normal function, with initiation and termination mechanisms continually being elucidated.
• "[Liver manifestation of circulatory disorders]." (2022) — PMID 35545561 — The liver receives 25% of cardiac output via the hepatic artery and portal vein.
• "Liver regeneration." (2002) — PMID 12086922 — The liver generally regenerates after injury while maintaining essential functions throughout regeneration, though the regenerative response can sometimes fail, become disorganized or incomplete, and abnormal regeneration contributes to fulminant hepatic failure, cirrhosis, and primary liver cancer.
• "Evaluation of abnormal liver tests." (2014) — PMID 24266911 — Blood biochemical tests detect acute and chronic liver injury before symptoms appear; aminotransferases and alkaline phosphatase are markers of injury, total bilirubin reflects hepatic metabolism, and albumin and PT assess synthetic function.
• "Gamma-glutamyltransferase-friend or foe within?" (2016) — PMID 27512925 — GGT resides mostly on the plasma membrane of most cells but is an enzyme more common in hepatocytes, used as a marker of liver injury and heavy drinking.
• "Gamma glutamyl transferase." (2001) — PMID 11563810 — Conditions that elevate GGT include obstructive liver disease, heavy alcohol consumption, and enzyme-inducing drugs.
• "[Elevated liver enzymes]." (2016) — PMID 27824421 — Patterns of elevation among three enzymes (aminotransferase-dominant / ALP/GGT-dominant = cholestasis / GGT-dominant = alcoholic or non-alcoholic fatty liver, etc.); extrahepatic diseases cause similar elevations; normal states during pregnancy and adolescence also show higher values; asymptomatic mild elevations warrant only retesting — over 30% of elevated aminotransferases spontaneously normalize during follow-up.
• "Available markers of excessive alcohol use." (2025) — PMID 40711388 — GGT correlates positively with alcohol consumption; conclusion: no single test marker alone reliably screens for heavy drinking, so it is combined with medical history and questionnaires.
• "Value of Liver Function Tests in Cirrhosis." (2022) — PMID 35677506 — No single test evaluates all liver functions; common tests (bilirubin, enzymes, albumin, PT) evaluate liver function only partially, so indices and scores combining multiple markers are used clinically.
• "Biomarkers of liver diseases." (2023) — PMID 37482588 — AST, ALT, ALP, GGT, and total bilirubin are routine liver markers but are not exclusive to the liver.
• "Guidelines on the management of abnormal liver blood tests." (2018) — PMID 29122851 — British Society of Gastroenterology guidelines, with the first question being "What constitutes an abnormal liver blood test?"
• "Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?" (2000) — PMID 11142566 — Up to 25% of chronic hepatitis C patients (10–40% depending on the study) have persistently normal aminotransferases; biopsy shows some degree of chronic liver disease in up to 80%, mostly mild with slower fibrosis progression.
• "A Systematic Approach to Patients with Jaundice." (2016) — PMID 27904243 — Yellowing of the eyes and skin is nonspecific as to cause, requiring a staged evaluation; clinical signs appear when serum bilirubin exceeds 2.5 to 3 mg/dL.
• "Evaluation of Jaundice in Adults." (2017) — PMID 28145671 — Unconjugated hyperbilirubinemia results from increased production due to red blood cell destruction or conjugation defects; conjugated hyperbilirubinemia results from hepatocyte injury such as viral or alcoholic hepatitis, and cholestasis such as gallstone or tumor obstruction.
• "Evaluation of Jaundice in Adults." (2025) — PMID 39823630 — Jaundice may signal serious underlying liver and biliary tract disease; initial tests include fractionated bilirubin, blood counts, AST, ALT, GGT, ALP, albumin, PT, and INR, followed by ultrasound, contrast-enhanced CT, or MRCP depending on the cause.